UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(MARK ONE)
☒ QUARTERLY REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended June 30, 2025
☐ TRANSITION REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 001-42659
ProCap Acquisition Corp
(Exact Name of Registrant as Specified in Its Charter)
Cayman Islands | | N/A |
(State or other jurisdiction of
incorporation or organization) | | (I.R.S. Employer
Identification No.) |
600 Lexington Ave, Floor 2 New York, New York | | 10022 |
(Address of principal executive offices) | | (Zip Code) |
(305) 938-0912
(Issuer’s telephone number)
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant | | PCAPU | | The Nasdaq Stock Market LLC |
Class A ordinary shares, par value $0.0001 per share | | PCAP | | The Nasdaq Stock Market LLC |
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share | | PCAPW | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes ☐ No ☒
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes
☒ No ☐
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | | Smaller reporting company | ☒ |
| | Emerging growth company | ☒ |
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As of August 8, 2025, there were 25,430,000
Class A Ordinary Shares, $0.0001 par value, and 6,250,000 Class B Ordinary Shares, $0.0001 par value, issued and outstanding, including
25,000,000 Class A Ordinary Shares subject to possible redemption.
PROCAP ACQUISITION CORP
FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2025
TABLE OF CONTENTS
|
|
Page |
Part I. Financial Information |
|
|
Item 1. Interim Financial Statements |
|
1 |
Balance Sheet as of June 30, 2025 (Unaudited) |
|
1 |
Statements
of Operations for the three months ended June 30, 2025 and for the period from January 2, 2025 (Inception) through June 30, 2025 (Unaudited) |
|
2 |
Statement of Changes in Shareholders’ Deficit for the three months ended June 30, 2025 and for the period from January 2, 2025 (Inception) through June 30, 2025 (Unaudited) |
|
3 |
Statement of Cash Flows for the period from January 2, 2025 (Inception) through June 30, 2025 (Unaudited) |
|
4 |
Notes to Financial Statements (Unaudited) |
|
5 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
18 |
Item 3. Quantitative and Qualitative Disclosures About Market Risk |
|
20 |
Item 4. Controls and Procedures |
|
20 |
Part II. Other Information |
|
|
Item 1. Legal Proceedings |
|
21 |
Item 1A. Risk Factors |
|
21 |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
|
22 |
Item 3. Defaults Upon Senior Securities |
|
22 |
Item 4. Mine Safety Disclosures |
|
22 |
Item 5. Other Information |
|
22 |
Item 6. Exhibits |
|
23 |
Part III. Signatures |
|
24 |
PART I - FINANCIAL INFORMATION
Item 1. Interim Financial Statements.
PROCAP ACQUISITION CORP
BALANCE SHEET
JUNE 30, 2025
(UNAUDITED)
Assets: | |
|
Current assets | |
|
Cash | |
$ | 1,367,369 | |
Prepaid expenses | |
| 124,995 | |
Total current assets | |
| 1,492,364 | |
Cash held in Trust Account | |
| 251,114,608 | |
Total Assets | |
$ | 252,606,972 | |
| |
| | |
Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | |
| | |
Current liabilities | |
| | |
Accrued offering costs | |
$ | 75,000 | |
Accrued expenses | |
| 49,178 | |
Over-allotment option liability | |
| 7,023 | |
Promissory note – related party | |
| 23,345 | |
Total current liabilities | |
| 154,546 | |
Deferred underwriting fee | |
| 11,250,000 | |
Total Liabilities | |
| 11,404,546 | |
| |
| | |
Commitments and Contingencies (Note 6) | |
| | |
Class A ordinary shares subject to possible redemption, $0.0001 par value; 25,000,000 shares at redemption value of $10.04 per share | |
| 251,114,608 | |
| |
| | |
Shareholders’ Deficit | |
| | |
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | |
| — | |
Class A ordinary shares, $0.0001 par value; 300,000,000 shares authorized; 430,000 shares issued and outstanding (excluding 25,000,000 shares subject to possible redemption) | |
| 43 | |
Class B ordinary shares, $0.0001 par value; 30,000,000 shares authorized; 6,325,000 shares issued and outstanding (1) | |
| 633 | |
Additional paid-in capital | |
| — | |
Accumulated deficit | |
| (9,912,858 | ) |
Total Shareholders’ Deficit | |
| (9,912,182 | ) |
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | |
$ | 252,606,972 | |
The accompanying notes are an integral part of
the unaudited financial statements.
PROCAP ACQUISITION CORP
STATEMENTS OF OPERATIONS
(UNAUDITED)
| |
For the Three Months Ended June 30, 2025 | | |
For the period from January 2, 2025 (Inception) Through June 30, 2025 | |
General and administrative costs | |
$ | 133,531 | | |
$ | 203,550 | |
Loss from Operations | |
| (133,531 | ) | |
| (203,550 | ) |
| |
| | | |
| | |
Other income: | |
| | | |
| | |
Change in fair value of over-allotment option liability | |
| 14,188 | | |
| 14,188 | |
Interest earned on cash held in Trust Account | |
| 1,114,608 | | |
| 1,114,608 | |
Total other income | |
| 1,128,796 | | |
| 1,128,796 | |
| |
| | | |
| | |
Net income | |
$ | 995,265 | | |
$ | 925,246 | |
| |
| | | |
| | |
Basic weighted average shares outstanding of Class A ordinary shares subject to possible redemption | |
| 10,833,333 | | |
| 5,446,927 | |
Basic net income per ordinary share, Class A ordinary shares subject to possible redemption | |
$ | 0.06 | | |
$ | 0.08 | |
Diluted weighted average shares outstanding of Class A ordinary shares subject to possible redemption | |
| 10,833,333 | | |
| 5,446,927 | |
Diluted net income per ordinary share, Class A ordinary shares subject to possible redemption | |
$ | 0.06 | | |
$ | 0.08 | |
Basic weighted average shares outstanding of Class A and Class B ordinary shares not subject to possible redemption(1) | |
| 6,011,333 | | |
| 5,542,011 | |
Basic net income per ordinary share, Class A and Class B ordinary shares not subject to possible redemption | |
$ | 0.06 | | |
$ | 0.08 | |
Diluted weighted average shares outstanding of Class A and Class B ordinary shares not subject to possible redemption | |
| 6,436,333 | | |
| 6,099,274 | |
Diluted net income per ordinary share, Class A and Class B ordinary shares not subject to possible redemption | |
$ | 0.06 | | |
$ | 0.08 | |
The accompanying notes are an integral part of
the unaudited financial statements.
PROCAP ACQUISITION CORP
STATEMENT OF CHANGES IN SHAREHOLDERS’
DEFICIT
FOR THE PERIOD FROM JANUARY 2, 2025 (INCEPTION)
THROUGH JUNE 30, 2025
(UNAUDITED)
| |
Class A Ordinary Shares | | |
Class B Ordinary Shares | | |
Additional Paid-in | | |
Accumulated | | |
Total Shareholders’ | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance — January 2, 2025 (inception) | |
| — | | |
$ | — | | |
| — | | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Class B ordinary shares issued to Sponsor (1) | |
| — | | |
| — | | |
| 6,325,000 | | |
| 633 | | |
| 24,367 | | |
| — | | |
| 25,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (70,019 | ) | |
| (70,019 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance – March 31, 2025 | |
| — | | |
$ | — | | |
| 6,325,000 | | |
$ | 633 | | |
$ | 24,367 | | |
$ | (70,019 | ) | |
$ | (45,019 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Accretion for Class A ordinary shares to redemption value | |
| — | | |
| — | | |
| — | | |
| — | | |
| (6,028,196 | ) | |
| 10,838,104 | | |
| 16,866,300 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Sale of Private Placement Units | |
| 430,000 | | |
| 43 | | |
| — | | |
| — | | |
| 4,299,957 | | |
| — | | |
| 4,300,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Fair Value of Public Warrants at issuance | |
| — | | |
| — | | |
| — | | |
| — | | |
| 1,816,667 | | |
| — | | |
| 1,816,667 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Allocated value of transaction costs to Private Placement Units, Public Warrants and Over-allotment option | |
| — | | |
| — | | |
| — | | |
| — | | |
| (112,795 | ) | |
| — | | |
| (112,795 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 995,265 | | |
| 995,265 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance – June 30, 2025 | |
| 430,000 | | |
$ | 43 | | |
| 6,325,000 | | |
$ | 633 | | |
$ | — | | |
$ | (9,912,858 | ) | |
$ | (9,912,182 | ) |
The accompanying notes are an integral part of
the unaudited financial statements.
PROCAP ACQUISITION CORP
STATEMENT OF CASH FLOWS
FOR THE PERIOD FROM JANUARY 2, 2025 (INCEPTION)
THROUGH JUNE 30, 2025
(UNAUDITED)
Cash Flows from Operating Activities: | |
|
Net income | |
$ | 925,246 | |
Adjustments to reconcile net income to net cash used in operating activities: | |
| | |
Payment of general and administrative costs through promissory note – related party | |
| 80,895 | |
Interest earned on cash held in Trust Account | |
| (1,114,608 | ) |
Change in fair value of over-allotment option liability | |
| (14,188 | ) |
Adjustment to accrued offering costs | |
| (35,000 | ) |
Changes in operating assets and liabilities: | |
| | |
Prepaid expenses | |
| (79,995 | ) |
Accrued expenses | |
| 49,178 | |
Net cash used in operating activities | |
| (188,472 | ) |
| |
| | |
Cash Flows from Investing Activities: | |
| | |
Investment of cash into Trust Account | |
| (250,000,000 | ) |
Net cash used in investing activities | |
| (250,000,000 | ) |
| |
| | |
Cash Flows from Financing Activities: | |
| | |
Proceeds from sale of Units, net of underwriting discounts paid | |
| 247,800,000 | |
Proceeds from sale of Private Placement Units | |
| 4,300,000 | |
Proceeds from promissory note | |
| (200,659 | ) |
Payment of offering costs | |
| (343,500 | ) |
Net cash provided by financing activities | |
| 251,555,841 | |
| |
| | |
Net Change in Cash | |
| 1,367,369 | |
Cash – Beginning of period | |
| — | |
Cash – End of period | |
$ | 1,367,369 | |
| |
| | |
Noncash investing and financing activities: | |
| | |
Deferred offering costs included in accrued offering costs | |
$ | 110,000 | |
Deferred offering costs paid through promissory note - related party | |
$ | 123,109 | |
Prepaid expenses paid by Sponsor in exchange for issuance of Class B ordinary shares | |
$ | 25,000 | |
Prepaid services paid by Sponsor through the promissory note – related party | |
$ | 20,000 | |
Accretion of Class A ordinary shares to redemption value | |
$ | 16,866,300 | |
Deferred underwriting fee payable | |
$ | 11,250,000 | |
The accompanying notes are an integral part of
the unaudited financial statements.
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 2025
(Unaudited)
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS
OPERATIONS
ProCap Acquisition Corp (the “Company”)
is a blank check company incorporated as a Cayman Islands exempted corporation on January 2, 2025. The Company was incorporated for
the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar Business
Combination with one or more businesses (the “Business Combination”). The Company has not selected any specific Business Combination
target and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any
Business Combination target with respect to an initial Business Combination with the Company.
As of June 30, 2025, the Company had not commenced
any operations. All activity for the period from January 2, 2025 (inception) through June 30, 2025 relates to the Company’s
formation and the initial public offering (the “Initial Public Offering”), which is described below. The Company will not
generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates
non-operating income in the form of interest income on investments from the proceeds derived from the Initial Public Offering which are
held in the Trust Account (as defined below). The Company has selected December 31 as its fiscal year end.
The registration statement for the Company’s
Initial Public Offering was declared effective on May 20, 2025. On May 22, 2025, the Company consummated the Initial Public Offering of
25,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public
Shares”), which includes the partial exercise by the underwriters of their over-allotment option in the amount of 3,000,000 Units,
at $10.00 per Unit, generating gross proceeds of $250,000,000. Each Unit consists of one Class A ordinary share and one-third of one redeemable
warrant (each, a “Public Warrant”).
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of 430,000 units (the “Private Placement Units”) at a price of $10.00 per
Private Placement Unit, in a private placement to the Company’s sponsor, ProCap Acquisition Sponsor, LLC (the “Sponsor”),
generating gross proceeds of $4,300,000. Each Private Placement Unit consists of one Class A ordinary share and one-third of one redeemable
warrant (the “Private Placement Warrants” and together with the Public Warrants, the “Warrants”). Each whole Warrant
entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment.
Transaction costs amounted to $14,026,609, consisting
of $2,200,000 of cash underwriting fee, $11,250,000 of deferred underwriting fee, and $576,609 of other offering costs.
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement Units, although
substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination (less deferred underwriting
commissions).
The Business Combination must be with one or more
target businesses that together have a fair market value equal to at least 80% of the net balance in the Trust Account (as defined below)
(excluding the amount of deferred underwriting discounts held and income taxes payable on the income earned on the Trust Account) at the
time of the signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination
if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise
acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment
Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able
to successfully effect a Business Combination.
Following the closing of the Initial Public Offering,
on May 22, 2025, an amount of $250,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units and the Private Placement
Units, was placed in the trust account (the “Trust Account”), with Odyssey Transfer and Trust Company acting as trustee. The
funds are initially to be held in cash, including demand deposit accounts at a bank, or invested only in U.S. government treasury
obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the
Investment Company Act, which invest only in direct U.S. government treasury obligations; the holding of these assets in this form
is intended to be temporary and for the sole purpose of facilitating the intended Business Combination. To mitigate the risk that might
be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that the Company holds
investments in the Trust Account, the Company may, at any time (based on management team’s ongoing assessment of all factors related
to the potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the Trust Account
and instead to hold the funds in the Trust Account in cash or in an interest bearing demand deposit account at a bank. Except with respect
to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from
the Initial Public Offering and the sale of the Private Placement Units will not be released from the Trust Account until the earliest
of (i) the completion of the Company’s initial Business Combination, (ii) the redemption of the Company’s public
shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of the Initial Public
Offering or by such earlier liquidation date as our board of directors may approve (the “Completion Window”), subject to applicable
law, or (iii) the redemption of the Company’s public shares properly submitted in connection with a shareholder vote to amend
the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s
obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Company’s public shares
if the Company has not consummated an initial Business Combination within the Completion Window or (B) with respect to any other
material provisions relating to shareholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the
Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of
the Company’s public shareholders.
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 2025
(Unaudited)
The Company will provide the Company’s public
shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination
either (i) in connection with a general meeting called to approve the initial Business Combination or (ii) without a shareholder
vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business
Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled
to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated
as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held
in the Trust Account (less income taxes payable), divided by the number of then outstanding public shares, subject to the limitations.
The amount in the Trust Account is initially valued at $10.00 per public share.
The ordinary shares subject to possible redemption
were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance
with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480
“Distinguishing Liabilities from Equity.”
The Company will have only the duration of the
Completion Window to complete the initial Business Combination. However, if the Company is unable to complete its initial Business Combination
within the Completion Window, the Company will as promptly as reasonably possible but not more than ten business days thereafter,
redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned on the funds held in the Trust Account (less income taxes payable and up to $100,000 of interest to pay dissolution expenses),
divided by the number of then outstanding public shares, which redemption will constitute full and complete payment for the public shares
and completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation or other
distributions, if any), subject to the Company’s obligations under Cayman Islands law to provide for claims of creditors and subject
to the other requirements of applicable law.
The Sponsor, officers and directors have entered
into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to
their founder shares and public shares in connection with the completion of the initial Business Combination or an earlier redemption
in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable
to facilitate the completion of the initial Business Combination; (ii) waive their redemption rights with respect to their founder
shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum
and articles of association; (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder
shares if the Company fails to complete the initial Business Combination within the Completion Window, although they will be entitled
to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial
Business Combination within the Completion Window and to liquidating distributions from assets outside the Trust Account; and (iv) vote
any founder shares held by them and any public shares purchased during or after the Initial Public Offering (including in open market
and privately-negotiated transactions) in favor of the initial Business Combination.
The Sponsor has agreed that it will be liable
to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective
target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business
Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the
actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per
share due to reductions in the value of the trust assets, less income taxes payable, provided that such liability will not apply to any
claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account
(whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of
the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended
(the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor
has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes
that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able
to satisfy those obligations.
Liquidity and Capital Resources
The Company’s liquidity needs up to June
30, 2025 have been satisfied through the loan under an unsecured promissory note from the Sponsor of up to $300,000 (see Note 5). As of
June 30, 2025, the Company had cash of $1,367,369 and working capital surplus of $1,337,818.
On May 22, 2025, the Company consummated the Initial
Public Offering of 25,000,000 Units, which includes the partial exercise by the underwriters of their over-allotment option in the amount
of 3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $250,000,000. Simultaneously with the closing of the Initial Public
Offering, the Company consummated the sale of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit, in a private
placement to the Sponsor, generating gross proceeds of $4,300,000.
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 2025
(Unaudited)
In order to fund working capital deficiencies
or finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team or any
of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If
the Company completes a Business Combination, the Company would repay such loaned amounts at that time. Up to $1,500,000 of such Working
Capital Loans may be converted into units of the post-Business Combination entity at a price of $10.00 per unit. The units would be identical
to the Private Placement Units. As of June 30, 2025, the Company had no borrowings under the Working Capital Loans.
In connection with the Company’s assessment
of going concern considerations in accordance with Accounting Standards Codification (“ASC”) 205-40, “Presentation of
Financial Statements - Going Concern,” while there was substantial doubt previously, due to the cash on hand and working capital
described above, the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating
its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating
a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate
its business prior to the initial Business Combination. The Company has 24 months to complete the initial Business Combination. Management
has determined that upon the receipt of the proceeds from the Initial Public Offering (see Note 3), the Company has sufficient funds to
finance the working capital needs of the Company within one year from the date of issuance of the unaudited financial statements.
NOTE 2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited financial statements
have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for
interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities
and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared
in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting.
Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results
of operations, or cash flows. In the opinion of management, the accompanying unaudited financial statements include all adjustments, consisting
of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows
for the periods presented.
The accompanying unaudited financial statements
should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on May 22, 2025,
as well as the Company’s Current Report on Form 8-K, as filed with the SEC on May 30, 2025. The interim results for the three months
ended June 30, 2025 and for the period from January 2, 2025 (inception) through June 30, 2025, are not necessarily indicative of
the results to be expected for the year ending December 31, 2025 or for any future periods.
Emerging Growth Company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012,
(the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable
to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the
auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that
a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies
but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means
that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth
company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 2025
(Unaudited)
Use of Estimates
The preparation of the unaudited financial statements in conformity
with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the unaudited financial statements and the reported amounts of expenses and other
income during the reporting period.
Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the unaudited financial statements, which management considered in formulating its estimate, could change
in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,367,369 in cash and no cash
equivalents as of June 30, 2025.
Cash Held in Trust Account
As of June 30, 2025, the assets held in the Trust
Account, amounting to $251,114,608, were held in interest bearing demand deposit account.
Concentration of Credit Risk
Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal
Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant
adverse impact on the Company’s financial condition, results of operations, and cash flows. As of June 30, 2025, the Company has
not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Offering Costs
The Company complies with the requirements of
the ASC 340-10-S99 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses of Offering.” Deferred
offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20,
“Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into
its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between
Class A ordinary shares and Warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value
of the Warrants and then to the Class A ordinary shares. Offering costs allocated to the Class A ordinary shares were charged to temporary
equity, and offering costs allocated to the Public Warrants and Private Placement Units were charged to shareholders’ deficit as
Public Warrants and Private Placement Warrants after management’s evaluation were accounted for under equity treatment.
Fair Value of Financial Instruments
The fair value of the Company’s assets and
liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying
amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Income Taxes
The Company accounts for income taxes under ASC
Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income
taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets
and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods
in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in
a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing
authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company
recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2025, there were
no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position.
The Company is considered to be an exempted Cayman
Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing
requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero.
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 2025
(Unaudited)
Net Income per Ordinary Share
Net income per ordinary share is computed by dividing
net income by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture.
Weighted average shares were reduced for the effect of an aggregate of 75,000 ordinary shares that are subject to forfeiture if the over-allotment
option is not exercised by the underwriters (see Note 5). As of June 30, 2025, the Company did not have any dilutive securities and other
contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company for the
periods presented.
| |
For the Three Months Ended
June 30, 2025 | | |
For the period from January 2, 2025
(Inception) through June 30, 2025 | |
| |
Class A – redeemable | | |
Class A and Class B non-redeemable | | |
Class A – redeemable | | |
Class A and Class B non-redeemable | |
Basic net income per ordinary share | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Allocation of net income | |
$ | 640,086 | | |
$ | 355,179 | | |
$ | 458,620 | | |
$ | 466,626 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Basic weighted average ordinary shares outstanding | |
| 10,833,333 | | |
| 6,011,033 | | |
| 5,446,927 | | |
| 5,542,011 | |
Basic net income per ordinary share | |
$ | 0.06 | | |
$ | 0.06 | | |
$ | 0.08 | | |
$ | 0.08 | |
| |
For the Three Months Ended
June 30, 2025 | | |
For the period from January 2, 2025
(Inception) through June 30, 2025 | |
| |
Class A – redeemable | | |
Class A and Class B non-redeemable | | |
Class A – redeemable | | |
Class A and Class B non-redeemable | |
Diluted net income per ordinary share | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Allocation of net income | |
$ | 624,334 | | |
$ | 370,931 | | |
$ | 436,485 | | |
$ | 488,761 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Diluted weighted average ordinary shares outstanding | |
| 10,833,333 | | |
| 6,436,333 | | |
| 5,446,927 | | |
| 6,099,274 | |
Diluted net income per ordinary share | |
$ | 0.06 | | |
$ | 0.06 | | |
$ | 0.08 | | |
$ | 0.08 | |
Derivative Financial Instruments
The Company evaluates its financial instruments
to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815,
“Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument
is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value
reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded
as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet
as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12 months
of the balance sheet date. The underwriters’ over-allotment option is deemed to be a freestanding financial instrument indexed on
the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480 if not fully exercised at the time of
the Initial Public Offering. On May 22, 2025, at the closing of the Company’s Initial Public Offering, the underwriters partially
exercised their over-allotment option.
Warrant Instruments
The Company accounted for the Public Warrants
issued in connection with the Initial Public Offering and the Private Placement Warrants issued as part of the Private Placement Units,
in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging”. Accordingly, the Company
evaluated and classified the Warrant instruments under equity treatment at their assigned values.
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 2025
(Unaudited)
Class A Ordinary Shares Subject to Possible
Redemption
The Public Shares contain a redemption feature
which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder
vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company
classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within
the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying
value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial
Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of
redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly,
as of June 30, 2025, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside
of the shareholders’ deficit section of the Company’s balance sheet. As of June 30, 2025, the Class A ordinary shares subject
to possible redemption reflected in the balance sheet are reconciled in the following table:
Gross proceeds | |
$ | 250,000,000 | |
Less: | |
| | |
Proceeds allocated to Public Warrants | |
| (1,816,667 | ) |
Proceeds allocated to over-allotment option | |
| (21,211 | ) |
Class A ordinary shares issuance costs | |
| (13,913,814 | ) |
Plus: | |
| | |
Initial measurement of carrying value to redemption value | |
| 15,751,692 | |
Remeasurement of carrying value to redemption value | |
| 1,114,608 | |
Class A Ordinary Shares subject to possible redemption, June 30, 2025 | |
$ | 251,114,608 | |
Recent Accounting Pronouncements
Management does not believe that any other recently
issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited financial
statements.
NOTE 3. INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering on May
22, 2025, the Company sold 25,000,000 Units, which includes the partial exercise by the underwriters of their over-allotment option
in the amount of 3,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share, and one-third
of one redeemable Public Warrant.
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 2025
(Unaudited)
Each Warrant will become exercisable 30 days after
the completion of the Company’s initial Business Combination and will expire five years after the completion of the Company’s
initial Business Combination or earlier upon redemption or liquidation. However, if the Company does not complete its initial Business
Combination within the Completion Window, the Warrants will expire at the end of such period. If the Company is unable to deliver registered
shares of common stock to the holder upon exercise of the Warrants during the exercise period, there will be no net cash settlement of
these Warrants and the Warrants will expire worthless, unless they may be exercised on a cashless basis in the circumstances described
in the warrant agreement. Once the warrants become exercisable, the Company may redeem the outstanding warrants in whole and not in part
at a price of $0.01 per warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the last sale
price of the Company’s shares of common stock equals or exceeds $18.00 per share for any 20 trading days within the 30-trading day
period commencing at any time after the shares underlying the warrants have become exercisable and ending on the third trading day before
the Company sends the notice of redemption to the warrant holders.
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial
Public Offering, the Sponsor purchased an aggregate of 430,000 Private Placement Units at a price of $10.00 per unit, or $4,300,000 in
the aggregate, in a private placement.
The Private Placement Units are identical
to the Public Units sold in the Initial Public Offering except that, so long as they are held by the Sponsor, the underwriters or
their permitted transferees, the Private Placement Units (i) may not (including the Class A ordinary shares issuable upon
exercise of these Private Placement Units), subject to certain limited exceptions, be transferred, assigned or sold by the holders until
30 days after the completion of the initial Business Combination and (ii) will be entitled to registration rights.
The Sponsor and the Company’s officers and
directors have entered into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption
rights with respect to their founder shares and public shares in connection with the completion of the initial Business Combination or
an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company
determines it is desirable to facilitate the completion of the initial Business Combination; (ii) waive their redemption rights with
respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s
amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation
to allow redemption in connection with the initial Business Combination or to redeem 100% of the public shares if the Company has not
consummated an initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating
to shareholders’ rights or pre-initial Business Combination activity; (iii) waive their rights to liquidating distributions
from the Trust Account with respect to their founder shares if the Company fails to complete the initial Business Combination within the
Completion Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares
they hold if the Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions
from assets outside the Trust Account; and (iv) vote any founder shares held by them and any public shares purchased during or after
the Initial Public Offering (including in open market and privately-negotiated transactions) in favor of the initial Business Combination.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On January 9, 2025, the Sponsor purchased,
and the Company issued to the Sponsor, 5,750,000 Class B ordinary shares (“founder shares”) for $25,000, or approximately
$0.004 per share. On May 20, 2025, the Company effected a share recapitalization pursuant to which the Company issued an additional 575,000
founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate 6,325,000 founder shares
issued and outstanding. All share and per share data has been retroactively presented. Up to 825,000 of the founder shares may be surrendered
by the Sponsor for no consideration depending on the extent to which the underwriters’ over-allotment option is exercised. On May
22, 2025, the underwriters partially exercised their over-allotment option, and as a result, 750,000 founder shares are no longer subject
to forfeiture and up to 75,000 of the founder shares may be surrendered by the Sponsor for no consideration depending on the extent to
which the remainder of the underwriters’ over-allotment option is not exercised. The remaining 75,000 founder shares were forfeited
as of July 6, 2025, the expiration date of the over-allotment option as it remained unexercised (see Note 9).
The Company’s initial shareholders have
agreed not to transfer, assign or sell any of their founder shares and any Class A ordinary shares issued upon conversion thereof
until the earlier to occur of (i) six months after the completion of the initial Business Combination or (ii) the date
on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination
that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities
or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Company’s initial
shareholders with respect to any founder shares (the “Lock-up”). Notwithstanding the foregoing, if (1) the closing price
of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the initial Business
Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s
shareholders having the right to exchange their shares for cash, securities or other property, the founder shares will be released from
the Lock-up.
Promissory Note — Related Party
The Sponsor has agreed to loan the Company an aggregate of up to $300,000
to be used for a portion of the expenses of the Initial Public Offering. The loan is non-interest bearing, unsecured and due at the earlier
of December 31, 2025, or the closing of the Initial Public Offering. As of June 30, 2025, the Company had an outstanding borrowing
of $23,345 under the promissory note, which is now due on demand. Borrowings under the note are no longer available.
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 2025
(Unaudited)
Administrative Services Agreement
The Company entered into an agreement with an
affiliate of the Sponsor, commencing on May 20, 2025 through the earlier of the Company’s consummation of initial Business Combination
and its liquidation, to pay the affiliate of the Sponsor an aggregate of $10,000 per month for office space, utilities, management, operations,
and secretarial and administrative support services. For the three months ended June 30, 2025 and for the period from January 2,
2025 (inception) through June 30, 2025, the Company incurred $10,000 in fees for these services.
Working Capital Loans
In order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may,
but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes
a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the
Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from
the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible
into private placement units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender. The units
would be identical to the Private Placement Units. As of June 30, 2025, no such Working Capital Loans were outstanding.
NOTE 6. COMMITMENTS AND CONTINGENCIES
Risks and Uncertainties
The United States and global markets are
experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the
recent escalation of the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization
(“NATO”) deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European
Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and
entities, including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication
payment system. Certain countries, including the United States, have also provided and may continue to provide military aid or other
assistance to Ukraine and to Israel, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and
the escalation of the Israel-Hamas conflict and the resulting measures that have been taken, and could be taken in the future, by NATO,
the United States, the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global
security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts
are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital
markets, as well as supply chain interruptions and increased cyberattacks against U.S. companies. Additionally, any resulting sanctions
could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.
Any of the above mentioned factors, or any other
negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine,
the escalation of the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company’s search
for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination.
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 2025
(Unaudited)
Registration Rights
The holders of the founder shares, Private Placement
Warrants and the Class A ordinary shares underlying such Private Placement Warrants and warrants that may be issued upon conversion
of the Working Capital Loans will have registration rights to require the Company to register for resale of any of the Company’s
securities held by them and any other securities of the Company acquired by them prior to the consummation of the initial Business Combination
pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering. The holders
of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities.
In addition, the holders have certain piggy-back registration rights with respect to registration statements filed subsequent to the completion
of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration
statements.
Underwriting Agreement
The underwriters have a 45-day option from the
date of the Initial Public Offering to purchase up to an additional 3,300,000 units to cover over-allotments, if any. On May 22,
2025, the underwriters partially exercised the over-allotment option to purchase an additional 3,000,000 Units. The underwriters have
45 days from the date of the Initial Public Offering to purchase the remaining 300,000 Units. The remaining over-allotment option expired
on July 6, 2025, as it remained unexercised (see Note 9).
The underwriters were entitled to a cash underwriting
discount of $2,200,000 (1.0% of the gross proceeds of the units offered in the Initial Public Offering), which was paid at the closing
of the Initial Public Offering. Additionally, the underwriters were entitled to a deferred underwriting discount of $11,250,000 (4.50%
of the gross proceeds of the Initial Public Offering held in the Trust Account), payable upon the completion of the Company’s initial
Business Combination subject to the terms of the underwriting agreement, but $0.10 per unit of such $0.45 per unit shall be due solely
on amounts remaining in the Trust Account following all properly submitted shareholder redemptions in connection with the consummation
of the initial Business Combination and $0.05 per unit of such $0.45 per unit shall be allocable by the Company.
NOTE 7. SHAREHOLDERS’ DEFICIT
Preference Shares — The
Company is authorized to issue a total of 1,000,000 preference shares at par value of $0.0001 each. As of June 30, 2025, there were no
preference shares issued or outstanding.
Class A Ordinary Shares — The
Company is authorized to issue a total of 300,000,000 Class A ordinary shares at par value of $0.0001 each. As of June 30, 2025,
there were 430,000 Class A ordinary shares issued and outstanding, excluding 25,000,000 shares subject to possible redemption.
Class B Ordinary Shares — The
Company is authorized to issue a total of 30,000,000 Class B ordinary shares at par value of $0.0001 each. As of June 30, 2025, there
were 6,325,000 Class B ordinary shares issued and outstanding. The founder shares include an aggregate of up to 75,000 shares subject
to forfeiture if the remainder of the over-allotment option is not exercised by the underwriters in full. The remaining founder shares
were forfeited on July 6, 2025, the expiration date of the over-allotment option, as the over-allotment option remained unexercised (see
Note 9).
The founder shares will automatically convert
into Class A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination or earlier
at the option of the holder on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary
shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in this offering and related
to or in connection with the closing of the initial Business Combination, the ratio at which Class B ordinary shares convert into
Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree
to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable
upon conversion of all Class B ordinary shares will equal, in the aggregate, 20% of the sum of (i) the total number of all Class A
ordinary shares outstanding upon the completion of this offering (including any Class A ordinary shares issued pursuant to the underwriters’
over-allotment option and excluding the Class A ordinary shares underlying the private placement warrants issued to the Sponsor),
plus (ii) all Class A ordinary shares and equity-linked securities issued or deemed issued, in connection with the closing of
the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial
Business Combination and any private placement-equivalent warrants issued to our Sponsor or any of its affiliates or to our officers or
directors upon conversion of working capital loans) minus (iii) any redemptions of Class A ordinary shares by public shareholders
in connection with an initial Business Combination; provided that such conversion of founder shares will never occur on a less than one-for-one
basis.
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 2025
(Unaudited)
Holders of record of the Company’s Class A
ordinary shares and Class B ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders.
Unless specified in the amended and restated memorandum and articles of association or as required by the Companies Act or stock exchange
rules, an ordinary resolution under Cayman Islands law and the amended and restated memorandum and articles of association, which requires
the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where
proxies are allowed, by proxy at the applicable general meeting of the Company is generally required to approve any matter voted on by
our shareholders. Approval of certain actions requires a special resolution under Cayman Islands law, which (except as specified below)
requires the affirmative vote of at least two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person
or, where proxies are allowed, by proxy at the applicable general meeting, and pursuant to the amended and restated memorandum and articles
of association, such actions include amending our amended and restated memorandum and articles of association and approving a statutory
merger or consolidation with another company. There is no cumulative voting with respect to the appointment of directors, meaning, following
our initial Business Combination, the holders of more than 50% of the ordinary shares voted for the appointment of directors can elect
all of the directors. Prior to the consummation of the initial Business Combination, only holders of the Class B ordinary shares
will (i) have the right to vote on the appointment and removal of directors and (ii) be entitled to vote on continuing our company
in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents or to adopt
new constitutional documents, in each case, as a result of our approving a transfer by way of continuation in a jurisdiction outside the
Cayman Islands). Holders of the Class A ordinary shares will not be entitled to vote on these matters during such time. These provisions
of the amended and restated memorandum and articles of association may only be amended if approved by a special resolution passed by the
affirmative vote of at least 90% (or, where such amendment is proposed in respect of the consummation of the initial Business Combination,
two-thirds) of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy
at the applicable general meeting of the Company.
Warrants — As of June 30,
2025, there were 8,476,666 Warrants outstanding, including 8,333,333 Public Warrants and 143,333 Private Placement Warrants. Each whole
Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as
discussed herein. The Warrants cannot be exercised until 30 days after the completion of the initial Business Combination, and will
expire at 5:00 p.m., New York City time, five years after the completion of the initial Business Combination or earlier
upon redemption or liquidation.
The Company will not be obligated to deliver any
Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless
a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective
and a prospectus relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue a Class A
ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the
event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant
will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be
required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser
of a unit containing such warrant will have paid the full purchase price for the unit solely for the Class A ordinary share underlying
such unit.
Under the terms of the warrant agreement, the
Company has agreed that, as soon as practicable, but in no event later than 20 business days, after the closing of its Business Combination,
it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement for the
Initial Public Offering or a new registration statement covering the registration under the Securities Act of the Class A
ordinary shares issuable upon exercise of the warrants and thereafter will use its commercially reasonable efforts to cause the same to
become effective within 60 business days following the Company’s initial Business Combination and to maintain a current prospectus
relating to the Class A ordinary shares issuable upon exercise of the warrants until the expiration of the warrants in accordance
with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise
of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial Business Combination,
warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have
failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of
the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise
of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under
Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their
warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event
the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company
does not so elect, the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky
laws to the extent an exemption is not available.
If the holders exercise their public warrants
on a cashless basis, they would pay the warrant exercise price by surrendering the warrants for that number of Class A ordinary shares
equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants,
multiplied by the excess of the “fair market value” of the Class A ordinary shares over the exercise price of the warrants
by (y) the fair market value. The “fair market value” is the average reported closing price of the Class A ordinary
shares for the 10 trading days ending on the third trading day prior to the date on which the notice of exercise is received
by the warrant agent or on which the notice of redemption is sent to the holders of warrants, as applicable.
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 2025
(Unaudited)
Redemption of Warrants When the Price per Class A
Ordinary Share Equals or Exceeds $18.00: The Company may redeem the outstanding warrants:
|
● |
in whole and not in part; |
| ● | at
a price of $0.01 per warrant; |
| ● | upon
a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); and |
| ● | if,
and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to
the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30-trading day
period commencing at least 30 days after completion of our initial Business Combination and ending three business days before
we send the notice of redemption to the warrant holders. |
Additionally, if the number of outstanding Class A
ordinary shares is increased by a share capitalization payable in Class A ordinary shares, or by a sub-division of ordinary shares
or other similar event, then, on the effective date of such share capitalization, sub-division or similar event, the number of Class A
ordinary shares issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding ordinary shares.
A rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase Class A ordinary shares
at a price less than the fair market value will be deemed a share capitalization of a number of Class A ordinary shares equal to
the product of (i) the number of Class A ordinary shares actually sold in such rights offering (or issuable under any other
equity securities sold in such rights offering that are convertible into or exercisable for Class A ordinary shares) and (ii) the
quotient of (x) the price per Class A ordinary share paid in such rights offering and (y) the fair market value. For these
purposes (i) if the rights offering is for securities convertible into or exercisable for Class A ordinary shares, in determining
the price payable for Class A ordinary shares, there will be taken into account any consideration received for such rights, as well
as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of
Class A ordinary shares as reported during the ten (10) trading day period ending on the trading day prior to the first
date on which the Class A ordinary shares trade on the applicable exchange or in the applicable market, regular way, without the
right to receive such rights.
Note 8 — Fair Value Measurements
The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
Level 1: |
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
|
|
Level 2: |
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
|
|
Level 3: |
Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability. |
The following table presents information about
the Company’s assets, liabilities, and equity, that are measured at fair value as of June 30, 2025, and indicates the fair value
hierarchy of the valuation inputs the Company utilized to determine such fair value:
| |
Level | |
June 30, 2025 |
Assets: | |
| |
| | |
Cash held in Trust Account | |
1 | |
$ | 251,114,608 | |
Liabilities: | |
| |
| | |
Over-allotment option liability | |
3 | |
$ | 7,023 | |
Equity: | |
| |
| | |
Fair value of Public Warrants for ordinary shares subject to possible redemption allocation | |
3 | |
$ | 1,816,667 | |
The over-allotment option was accounted for as
a liability in accordance with ASC 815-40 and was presented within liabilities on the balance sheet. The over-allotment option liability
is measured at fair value at inception and on a recurring basis, with changes in fair value presented within changes in fair value of
over-allotment option liability in the statement of operations.
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 2025
(Unaudited)
The Company used a Black-Scholes model to value
the over-allotment option. The over-allotment option liability was classified within Level 3 of the fair value hierarchy at the measurement
dates due to the use of unobservable inputs inherent in pricing models are assumptions related to expected share-price volatility, expected
life and risk-free interest rate. The Company estimates the volatility of its ordinary shares based on historical volatility that matches
the expected remaining life of the option. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant
date for a maturity similar to the expected remaining life of the option. The expected life of the option is assumed to be equivalent
to their remaining contractual term.
The key inputs into the Black-Scholes model were
as follows for the over-allotment option:
Inputs | |
May 22,
2025 (initial measurement) | | |
June 30,
2025 | |
Risk-free interest rate | |
| 4.37 | % | |
| 4.28 | % |
Expected term (years) | |
| 0.12 | | |
| 0.02 | |
Expected volatility | |
| 2.75 | % | |
| 3.86 | % |
Exercise price | |
$ | 10.00 | | |
$ | 10.00 | |
Fair value of over-allotment unit | |
$ | 0.071 | | |
$ | 0.023 | |
The fair value of the initial over-allotment option liability was $21,211.
During the three months ended June 30, 2025 and the period from January 2, 2025 (inception) through June 30, 2025, the company recognized
other income of $14,188 attributable to the change in the fair value of the over-allotment option liability. The fair value of the over-allotment
option liability included in the Company’s balance sheet as of June 30, 2025 was $7,023.
The fair value of the Public Warrants is $1,816,667,
or $0.218 per Public Warrant. The fair value of Public Warrants was determined using Monte Carlo Simulation Model. The Public Warrants
have been classified within shareholders’ deficit and will not require remeasurement after issuance. The Public Warrants was classified
within Level 3 of the fair value hierarchy at the measurement dates due to the use of unobservable inputs inherent in pricing models are
assumptions related to volatility, remaining term in years, risk free rate, pre-adjusted value per share and implied market adjustment.
The following table presents the quantitative information regarding market assumptions used in the valuation of the Public Warrants:
| |
May 22, 2025 | |
Underlying stock price | |
$ | 10.72 | |
Exercise price | |
$ | 11.50 | |
Volatility | |
| 5.3 | % |
Remaining term (years) | |
| 7.01 | |
Risk-free rate | |
| 4.23 | % |
Pre-adjusted value per share | |
$ | 2.18 | |
Implied market adjustment | |
| 10.0 | % |
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
JUNE 30, 2025
(Unaudited)
NOTE 8. SEGMENT INFORMATION
ASC Topic 280, “Segment Reporting,”
establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic
areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is
available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources
and assess performance.
The Company’s chief operating decision maker
has been identified as the Chief Executive Officer (“CODM”), who reviews the operating results for the Company as a whole
to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company
only has one operating segment.
The key measures of segment profit or loss reviewed by the CODM are
interest on the Trust Account and general and administrative expenses. The CODM reviews interest earned on the Trust Account to measure
and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance
with the trust agreement. General and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure
enough capital is available to complete a business combination within the Business Combination period. The CODM also reviews general and
administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.
The segment measures of profitability are shown
in the statements of operations. The measure of segment assets is reported on the balance sheet as total assets.
NOTE 9. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred
after the balance sheet date up to the date that the unaudited financial statements were issued. Based upon this review, other than as
described below or within these financial statements, the Company did not identify any subsequent events that would have required adjustment
or disclosure in the unaudited financial statements.
As of June 30, 2025, the founder shares included
an aggregate of up to 75,000 shares subject to forfeiture if the remainder of the over-allotment option is not exercised by the underwriters
in full. The remaining founder shares were forfeited on July 6, 2025, the expiration date of the over-allotment option, as the over-allotment
option remained unexercised.
Item 2. Management’s Discussion and Analysis
of Financial Condition and Results of Operations
References in this report (the “Quarterly
Report”) to “we,” “us” or the “Company” refer to ProCap Acquisition Corp, a blank check company
incorporated as a Cayman Islands exempted company. References to our “management” or our “management team” refer
to our officers and directors, and references to the “Sponsor” refer to ProCap Acquisition Sponsor, LLC. The following discussion
and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements
and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth
below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking
statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical
facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All
statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination
(as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations,
are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,”
“estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking
statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs,
based on information currently available. A number of factors could cause actual events, performance or results to differ materially from
the events, performance and results discussed in the forward-looking statements, including that the conditions of the Proposed Business
Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from
those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus
for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities
filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities
law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information,
future events or otherwise.
Overview
We are a blank check company incorporated in the
Cayman Islands on January 2, 2025 formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition,
share purchase, reorganization or other similar Business Combination with one or more businesses. We intend to effectuate our Business
Combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Placement Units, our shares,
debt or a combination of cash, shares and debt.
We expect to continue to incur significant costs
in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor
generated any revenues to date. Our only activities from January 2, 2025 (inception) through June 30, 2025 were organizational activities,
those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a Business Combination.
We do not expect to generate any operating revenues until after the completion of our Business Combination. Subsequent to the Initial
Public Offering, we generate non-operating income in the form of interest income on cash held in the Trust Account. We incur expenses
as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence
expenses.
For the three months ended June 30, 2025, we had
net income of $995,265, which consisted of interest earned on cash held in Trust Account of $1,114,608 and a change in the fair value
of the over-allotment option liability of $14,188, offset by general and administrative costs of $133,531.
For the period from January 2, 2025 (inception) through June 30,
2025, we had net income of $925,246, which consisted of interest earned on cash held in Trust Account of $1,114,608 and a change in the
fair value of the over-allotment option liability of $14,188, offset by general and administrative costs of $203,550.
Liquidity and Capital Resources
Until the consummation of the Initial Public Offering,
our only source of liquidity was an initial purchase of shares of Class B ordinary shares, par value $0.0001 per share, by the Sponsor
and loans from the Sponsor.
On May 22, 2025, we consummated the Initial Public
Offering of 25,000,000 Units, which includes the partial exercise by the underwriters of their over-allotment option in the amount of
3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $250,000,000. Simultaneously with the closing of the Initial Public
Offering, we consummated the sale of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit, in a private placement
to the Sponsor, generating gross proceeds of $4,300,000.
Following the closing of the Initial Public Offering
and the private placement, a total of $250,000,000 was placed in the Trust Account. We incurred $14,026,609 in fees, consisting of $2,200,000
of cash underwriting fee, $11,250,000 of deferred underwriting fee, and $576,609 of other offering costs.
For the period from January 2, 2025 (inception)
through June 30, 2025, cash used in operating activities was $188,472. The net income of $925,246 was affected by the following non-cash
and working capital items: interest income of $1,114,608, on cash held in the Trust Account, a $35,000 adjustment to accrued offering costs,
and a $14,188 change in the fair value of the over-allotment option liability. These were partially offset by $80,895 in general and administrative
expenses paid through the promissory note – related party. Additionally, changes in operating assets and liabilities used $30,817
in cash for operating activities.
We intend to use substantially all of the funds
held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete
our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our
Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the
target business or businesses, make other acquisitions and pursue our growth strategies.
We intend to use the funds held outside the Trust
Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel
to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate
documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies
or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their
affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such
loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the
Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of
such Working Capital Loans may be convertible into private placement units of the post Business Combination entity at a price of $10.00
per unit. The units issued upon conversion of any such loans would be identical to the Private Placement Units sold in a private placement
concurrently with the Initial Public Offering.
We do not believe we will need to raise additional
funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target
business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so,
we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional
financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares
upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such
Business Combination.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities,
which would be considered off-balance sheet arrangements as of June 30, 2025. We do not participate in transactions that create relationships
with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established
for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of the Sponsor an aggregate
of $10,000 per month for office space, utilities, management, operations, and secretarial and administrative support services.
The underwriters were entitled to a deferred underwriting
discount of $11,250,000 (4.50% of the gross proceeds of the Initial Public Offering held in the Trust Account), payable upon the completion
of the Company’s initial Business Combination subject to the terms of the underwriting agreement, but $0.10 per unit of such $0.45
per unit shall be due solely on amounts remaining in the Trust Account following all properly submitted shareholder redemptions in connection
with the consummation of the initial Business Combination and $0.05 per unit of such $0.45 per unit shall be allocable by the Company.
Critical Accounting Estimates
The preparation of the unaudited financial statements
and related disclosures in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts
of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited financial statements, and income
and expenses during the periods reported. Making estimates requires Management to exercise significant judgment. It is at least reasonably
possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited financial
statements, which Management considered in formulating its estimate, could change in the near term due to one or more future confirming
events. Accordingly, the actual results could materially differ from those estimates. As of June 30, 2025, we did not have any critical
accounting estimates to be disclosed.
Item 3. Quantitative and Qualitative Disclosures
About Market Risk
We are a smaller reporting company as defined
by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed
to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported
within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our
management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate
to allow timely decisions regarding required disclosure.
As required by Rules 13a-15 and 15d-15 under the
Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and
operation of our disclosure controls and procedures as of December 31, 2024. Based upon their evaluation, our Chief Executive Officer
and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the
Exchange Act) were not effective due to the material weakness of inadequate segregation of duties within account processes due to limited
personnel and insufficient written policies and procedures for accounting, IT, and financial reporting and record keeping.
We do not expect that our disclosure controls
and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and
operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met.
Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits
must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation
of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances
of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of
future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Control over Financial
Reporting
There was no change in our internal control over financial reporting
that occurred during the second fiscal quarter of 2025 covered by this Quarterly Report on Form 10-Q that has materially affected, or
is reasonably likely to materially affect, our internal control over financial reporting.
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
To the knowledge of our management, there is no
material litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against
any of our property.
Item 1A. Risk Factors
As a smaller reporting company under Rule 12b-2
of the Exchange Act, we are not required to include risk factors in this Report. For additional risks relating to our operations, other
than as set forth below, see the section titled “Risk Factors” contained in our final prospectus for our Initial Public Offering
filed with the SEC (the “IPO Registration Statement”). Any of these factors could result in a significant or material adverse
effect on our results of operations or financial condition. Additional risks could arise that may also affect our business or ability
to consummate an initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time
to time in our future filings with the SEC.
Changes in international trade policies,
tariffs and treaties affecting imports and exports may have a material adverse effect on our search for an initial Business Combination
target or the performance or business prospects of a post-Business Combination company.
There have recently been significant changes to
international trade policies and tariffs affecting imports and exports. Any significant increases in tariffs on goods or materials or
other changes in trade policy could negatively affect our search for a target and/or our ability to complete our initial Business Combination.
Recently, the United States has implemented a
range of new tariffs and increases to existing tariffs. In response to the tariffs announced by the United States, other countries have
imposed, are considering imposing, and may in the future impose new or increased tariffs on certain exports from the United States. There
is currently significant uncertainty about the future relationship between the United States and other countries with respect to trade
policies, taxes, government regulations and tariffs. and we cannot predict whether, and to what extent, current tariffs will continue
or trade policies will change in the future.
Tariffs, or the threat of tariffs or increased
tariffs, could have a significant negative impact on certain businesses (either due to domestic businesses’ reliance on imported
goods or dependence on access to foreign markets, or foreign businesses’ reliance on sales into the United States). In addition,
retaliatory tariffs could have a significant negative impact on foreign businesses that rely on imports from the United States, and domestic
businesses that rely on exporting goods internationally. These tariffs and threats of tariffs and other potential trade policy changes
could negatively affect the attractiveness of certain initial Business Combination targets, or lead to material adverse effects on a post-Business
Combination company. Among other things, historical financial performance of companies affected by trade policies and/or tariffs may not
provide useful guidance as to the future performance of such companies, because future financial performance of those companies may be
materially affected by new U.S. tariffs or foreign retaliatory tariffs, or other changes to trade policies. The business prospects of
a particular target for a Business Combination could change even after we enter into a Business Combination agreement, as a result of
tariffs or the threat of tariffs that may have a material impact on that target’s business, and it may be costly or impractical
for us to terminate that Business Combination agreement. These factors could affect our selection of a Business Combination target.
We may not be able to adequately address the risks
presented by these tariffs or other potential trade policy changes. As a result, we may deem it costly, impractical or risky to complete
an initial Business Combination with a particular target or with a target in a particular industry or from a particular country. Consequently,
the pool of potential target companies may be reduced, which could impair our ability to identify a suitable target and to complete an
initial Business Combination. If we complete an initial Business Combination with such a target, the post-Business Combination company’s
operations and financial results could be adversely affected as a result of tariffs or changes to trade policies, which may cause the
market value of the securities of the post-Business Combination company to decline.
Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.
Unregistered Sales of Equity Securities
On May 22, 2025, the Company consummated the Initial
Public Offering of 25,000,000 Units, which includes the partial exercise by the underwriters of their over-allotment option in the amount
of 3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $250,000,000. The securities sold in the offering were registered
under the Securities Act on registration statement on Form S-1 (Nos. 333-286876 and 333-287454). The SEC declared the registration
statement effective on May 20, 2025.
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit,
in a private placement to the Sponsor, generating gross proceeds to the Company of $4,300,000. The Private Placement Units (and underlying
securities) are identical to the Units sold in the Initial Public Offering, except as otherwise disclosed in our IPO Registration Statement.
No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant
to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
Use of Proceeds
Following the closing of our Initial Public Offering
on May 22, 2025, a total of $250,000,000 (which amount includes $11,250,000 of the Deferred Fee) was placed in a U.S.-based Trust Account
maintained by Odyssey Transfer and Trust Company, acting as trustee. The proceeds held in the Trust Account may be invested by the trustee
only in U.S. government securities with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury
obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. The Company may, at any time (based on management
team’s ongoing assessment of all factors related to the potential status under the Investment Company Act), instruct the trustee
to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest bearing
demand deposit account at a bank. To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment
Company Act, which risk increases the longer that we hold investments in the Trust Account, we may, at any time (based on the Management
Team’s ongoing assessment of all factors related to the potential status under the Investment Company Act), instruct the trustee
to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest-bearing
demand deposit account at a bank.
Transaction costs amounted to $14,026,609, consisting
of $2,200,000 of cash underwriting fee, $11,250,000 of deferred underwriting fee, and $576,609 of other offering costs.
The remaining proceeds from the Initial Public
Offering and the Private Placement are held outside the Trust Account. Such funds are being used primarily to enable us to identify a
target and to negotiate and consummate our initial Business Combination.
There has been no material change in the planned
use of the proceeds from our Initial Public Offering and the Private Placement as described in the IPO Registration Statement. The specific
investments in our Trust Account may change from time to time.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
Trading Arrangements
During the quarterly period ended June 30, 2025,
none of our directors or officers (as defined in Rule 16a-1(f) promulgated under the Exchange Act) adopted or terminated any “Rule
10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of
Regulation S-K.
Additional Information
None.
Item 6. Exhibits
The following exhibits are filed as part of, or
incorporated by reference into, this Quarterly Report on Form 10-Q.
No. |
|
Description of Exhibit |
3.1 |
|
Amended and Restated Memorandum and Articles of Association, incorporated by reference to Exhibit 3.1 of the Company’s Form 8-K, as filed with the SEC on May 27, 2025. |
4.1 |
|
Specimen Unit Certificate, incorporated by reference to Exhibit 4.1 of the Company’s Form S-1, as filed with the SEC on April 30, 2025. |
4.2 |
|
Specimen Ordinary Share Certificate, incorporated by reference to Exhibit 4.2 the Company’s Form S-1, as filed with the SEC on April 30, 2025. |
4.3 |
|
Specimen Warrant Certificate (included as an exhibit to Exhibit 4.4). |
4.4 |
|
Warrant Agreement, dated May 20, 2025, between Odyssey Transfer and Trust Company and the Registrant, incorporated by reference to Exhibit 4.4 of the Company’s Form S-1, as filed with the SEC on April 30, 2025. |
10.1 |
|
Letter Agreement, dated May 20, 2025, between the Registrant, ProCap Acquisition Sponsor, LLC and each of the officer and directors of the Registrant, incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K, as filed with the SEC on May 27, 2025. |
10.2 |
|
Investment Management Trust Agreement, dated May 20, 2025, between Odyssey Transfer and Trust Company and the Registrant, incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K, as filed with the SEC on May 27, 2025. |
10.3 |
|
Form of Registration Rights Agreement, dated May 20, 2025, among the Registrant and ProCap Acquisition Sponsor, LLC, incorporated by reference to Exhibit 10.3 of the Company’s Form 8-K, as filed with the SEC on May 27, 2025. |
10.4 |
|
Private Placement Unit Purchase Agreement, dated May 20, 2025, between the Registrant and ProCap Acquisition Sponsor, LLC, incorporated by reference to the Company’s Form 8-K, as filed with the SEC on May 27, 2025. |
10.5 |
|
Form of Indemnity Agreement, as incorporated by reference to the Company’s Form 8-K, as filed with the SEC on May 27, 2025. |
10.6 |
|
Promissory Note dated January 9, 2025, issued to ProCap Acquisition Sponsor, LLC and the Registrant, incorporated by reference to Exhibit 10.6 of the Company’s Form S-1, as filed with the SEC on April 30, 2025. |
10.7 |
|
Securities Subscription Agreement dated January 9, 2025, between ProCap Acquisition Sponsor, LLC and the Registrant, incorporated by reference to Exhibit 10.7 of the Company’s Form S-1, as filed with the SEC on April 30, 2025. |
10.8 |
|
Administrative Services Agreement, dated May 20,2025, between the Registrant and an affiliate of the Registrant, incorporated by reference to Exhibit 10.6 of the Company’s Form 8-K, as filed with the SEC on May 27, 2025. |
31.1* |
|
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
31.2* |
|
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
32.1** |
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
32.2** |
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
99.1 |
|
Press Release dated July 9, 2025, incorporated by reference to the Company’s Form 8-K, as filed with the SEC on July 10, 2025.. |
101.INS* |
|
Inline XBRL Instance Document. |
101.SCH* |
|
Inline XBRL Taxonomy Extension Schema Document. |
101.CAL* |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
101.DEF* |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document. |
101.LAB* |
|
Inline XBRL Taxonomy Extension Label Linkbase Document. |
101.PRE* |
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
104* |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
** |
These certifications are furnished to the
SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as
shall be expressly set forth by specific reference in such filing. |
SIGNATURES
In accordance with the requirements
of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
PROCAP ACQUISITION CORP |
|
|
|
Date: August 11, 2025 |
By: |
/s/ Anthony J. Pompliano III |
|
Name: |
Anthony J. Pompliano III |
|
Title: |
Chief Executive Officer |
|
|
(Principal Executive Officer) |
|
|
|
Date: August 11, 2025 |
By: |
/s/ Catalina Abbey |
|
Name: |
Catalina Abbey |
|
Title: |
Chief Financial Officer |
|
|
(Principal Financial and Accounting Officer) |
24
00-0000000
1500000
http://fasb.org/srt/2025#ChiefExecutiveOfficerMember
0002056634
false
Q2
--12-31
0002056634
2025-01-01
2025-06-30
0002056634
pcapu:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember
2025-01-01
2025-06-30
0002056634
pcapu:ClassAOrdinarySharesParValue00001PerShareMember
2025-01-01
2025-06-30
0002056634
pcapu:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember
2025-01-01
2025-06-30
0002056634
us-gaap:CommonClassAMember
2025-08-08
0002056634
us-gaap:CommonClassBMember
2025-08-08
0002056634
2025-06-30
0002056634
us-gaap:RelatedPartyMember
2025-06-30
0002056634
us-gaap:CommonClassAMember
2025-06-30
0002056634
us-gaap:CommonClassBMember
2025-06-30
0002056634
2025-04-01
2025-06-30
0002056634
2025-01-02
2025-06-30
0002056634
pcapu:ClassAOrdinarySharesSubjectToPossibleRedemptionMember
2025-04-01
2025-06-30
0002056634
pcapu:ClassAOrdinarySharesSubjectToPossibleRedemptionMember
2025-01-02
2025-06-30
0002056634
pcapu:ClassAAndClassBOrdinarySharesNotSubjectToPossibleRedemptionMember
2025-04-01
2025-06-30
0002056634
pcapu:ClassAAndClassBOrdinarySharesNotSubjectToPossibleRedemptionMember
2025-01-02
2025-06-30
0002056634
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2025-01-01
0002056634
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2025-01-01
0002056634
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
0002056634
us-gaap:RetainedEarningsMember
2025-01-01
0002056634
2025-01-01
0002056634
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2025-01-02
2025-03-31
0002056634
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2025-01-02
2025-03-31
0002056634
us-gaap:AdditionalPaidInCapitalMember
2025-01-02
2025-03-31
0002056634
us-gaap:RetainedEarningsMember
2025-01-02
2025-03-31
0002056634
2025-01-02
2025-03-31
0002056634
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2025-03-31
0002056634
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2025-03-31
0002056634
us-gaap:AdditionalPaidInCapitalMember
2025-03-31
0002056634
us-gaap:RetainedEarningsMember
2025-03-31
0002056634
2025-03-31
0002056634
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2025-04-01
2025-06-30
0002056634
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2025-04-01
2025-06-30
0002056634
us-gaap:AdditionalPaidInCapitalMember
2025-04-01
2025-06-30
0002056634
us-gaap:RetainedEarningsMember
2025-04-01
2025-06-30
0002056634
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2025-06-30
0002056634
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2025-06-30
0002056634
us-gaap:AdditionalPaidInCapitalMember
2025-06-30
0002056634
us-gaap:RetainedEarningsMember
2025-06-30
0002056634
us-gaap:IPOMember
2025-05-22
2025-05-22
0002056634
us-gaap:OverAllotmentOptionMember
2025-05-22
2025-05-22
0002056634
us-gaap:OverAllotmentOptionMember
2025-05-22
0002056634
us-gaap:IPOMember
2025-01-02
2025-06-30
0002056634
us-gaap:PrivatePlacementMember
2025-01-02
2025-06-30
0002056634
us-gaap:PrivatePlacementMember
2025-06-30
0002056634
us-gaap:WarrantMember
us-gaap:CommonClassAMember
2025-06-30
0002056634
2025-05-22
2025-05-22
0002056634
2025-05-22
0002056634
pcapu:BusinessCombinationAgreementMember
2025-06-30
0002056634
pcapu:PublicShareMember
2025-06-30
0002056634
pcapu:SponsorMember
pcapu:PromissoryNoteMember
2025-06-30
0002056634
us-gaap:PrivatePlacementMember
2025-05-22
2025-05-22
0002056634
us-gaap:PrivatePlacementMember
2025-05-22
0002056634
pcapu:ClassARedeemableMember
2025-04-01
2025-06-30
0002056634
pcapu:ClassAAndClassBNonRedeemableMember
2025-04-01
2025-06-30
0002056634
pcapu:ClassARedeemableMember
2025-01-02
2025-06-30
0002056634
pcapu:ClassAAndClassBNonRedeemableMember
2025-01-02
2025-06-30
0002056634
pcapu:ClassAOrdinarySharesSubjectToPossibleRedemptionMember
2025-06-30
0002056634
us-gaap:IPOMember
2025-05-22
0002056634
pcapu:PublicWarrantsMember
2025-01-02
2025-06-30
0002056634
pcapu:PublicWarrantsMember
2025-06-30
0002056634
pcapu:SponsorMember
us-gaap:CommonClassBMember
2025-01-09
2025-01-09
0002056634
pcapu:SponsorMember
us-gaap:CommonClassBMember
2025-01-09
0002056634
pcapu:SponsorMember
2025-05-20
2025-05-20
0002056634
pcapu:FounderShareMember
pcapu:SponsorMember
2025-05-20
0002056634
pcapu:FounderShareMember
2025-05-20
2025-05-20
0002056634
pcapu:FounderShareMember
2025-05-22
2025-05-22
0002056634
us-gaap:SubsequentEventMember
2025-07-06
2025-07-06
0002056634
pcapu:FounderShareMember
2025-06-30
0002056634
us-gaap:RelatedPartyMember
2025-06-30
0002056634
pcapu:SponsorMember
2025-06-30
0002056634
us-gaap:OverAllotmentOptionMember
pcapu:UnderwritingAgreementMember
2025-01-02
2025-06-30
0002056634
us-gaap:OverAllotmentOptionMember
pcapu:UnderwritingAgreementMember
2025-05-22
2025-05-22
0002056634
us-gaap:IPOMember
pcapu:UnderwritingAgreementMember
2025-05-22
2025-05-22
0002056634
pcapu:UnderwritersMember
us-gaap:IPOMember
2025-05-22
2025-05-22
0002056634
pcapu:UnderwritingAgreementMember
2025-01-02
2025-06-30
0002056634
pcapu:UnderwritingAgreementMember
2025-06-30
0002056634
pcapu:SponsorMember
2025-01-02
2025-06-30
0002056634
us-gaap:CommonClassAMember
2025-01-02
2025-06-30
0002056634
us-gaap:CommonClassBMember
2025-01-02
2025-06-30
0002056634
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2025-06-30
0002056634
us-gaap:WarrantMember
2025-06-30
0002056634
pcapu:PrivatePlacementWarrantsMember
2025-06-30
0002056634
us-gaap:WarrantMember
2025-01-02
2025-06-30
0002056634
us-gaap:WarrantMember
us-gaap:CommonClassAMember
2025-01-02
2025-06-30
0002056634
us-gaap:OverAllotmentOptionMember
2025-01-02
2025-06-30
0002056634
us-gaap:FairValueInputsLevel1Member
2025-06-30
0002056634
us-gaap:FairValueInputsLevel3Member
2025-06-30
0002056634
us-gaap:FairValueInputsLevel3Member
2025-01-01
2025-06-30
0002056634
us-gaap:MeasurementInputRiskFreeInterestRateMember
pcapu:InitialMeasurementMember
2025-05-22
0002056634
us-gaap:MeasurementInputRiskFreeInterestRateMember
2025-06-30
0002056634
us-gaap:MeasurementInputExpectedTermMember
pcapu:InitialMeasurementMember
2025-05-22
0002056634
us-gaap:MeasurementInputExpectedTermMember
2025-06-30
0002056634
us-gaap:MeasurementInputPriceVolatilityMember
pcapu:InitialMeasurementMember
2025-05-22
0002056634
us-gaap:MeasurementInputPriceVolatilityMember
2025-06-30
0002056634
us-gaap:MeasurementInputExercisePriceMember
pcapu:InitialMeasurementMember
2025-05-22
0002056634
us-gaap:MeasurementInputExercisePriceMember
2025-06-30
0002056634
pcapu:FairValueOfOverAllotmentUnitMember
pcapu:InitialMeasurementMember
2025-05-22
0002056634
pcapu:FairValueOfOverAllotmentUnitMember
2025-06-30
0002056634
us-gaap:MeasurementInputSharePriceMember
2025-05-22
0002056634
us-gaap:MeasurementInputExercisePriceMember
2025-05-22
0002056634
us-gaap:MeasurementInputPriceVolatilityMember
2025-05-22
0002056634
us-gaap:MeasurementInputExpectedTermMember
2025-05-22
0002056634
us-gaap:MeasurementInputRiskFreeInterestRateMember
2025-05-22
0002056634
pcapu:PreadjustedValuePerShareMember
2025-05-22
0002056634
pcapu:ImpliedMarketAdjustmentMember
2025-05-22
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
pcapu:Segment